ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/06/2026
Voltar para busca
Dado oficial do USPTO
ORIGINALMINE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
06/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
12/07/2021
Data de registro
28/03/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/03/2023
Última transação
06/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
KR
Examinador
SWIFT, GILBERT M
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
CG Bio Co., Ltd.
Representantes
Diane J. Mason Faegre Drinker Biddle & Reath LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Arterial grafts; implants comprising living tissue; surgical implants comprising living tissue; processed human donor skin for the replacement of soft tissue; live organs and tissues being surgical implants comprised of living tissue for surgical purpose; surgical implants comprised of living tissues; living tissue transplants in the nature of implants comprising living tissue; human allograft tissue; implants for guided tissue regenerationimplants comprising living tissue; implantable materials for use in guided tissue regeneration in the nature of implants comprising living tissue; surgical implants comprised of living tissuesgrown from stem cells; skin grafts; living tissue vascular grafts; syringes sold filled with hyaluronic acid for medical purposes; pre-filled syringes of hyaluronic acid for medical purposes; medicinal infusions for treating soft tissue infections of the skin; medicinal infusionsmedicated skin care preparations for treating the lips and face; medicinal infusions for breast augmentation and penis enlargement; medicinal infusions for implanting artificial bones; medicinal infusions with demineralized bone matrix (DBM)biocompatible ceramic material and poloxamers derived from human tissuefor accelerating bone formation; pharmaceutical preparations for the treatment of wounds; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating epidermal problems; pharmaceutical preparations for treating damaged skin and tissue; medicines for human purposesmedicated skin care preparations for treating foot ulcersdry and itchy skinpostoperative wounds and burned skin; injectable dermal fillers; implantable medicines being surgical implants comprised of living tissues
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/02/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/08/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
13/07/2023
FIMP
FINAL DISPOSITION PROCESSED
13/07/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
28/06/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
28/03/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
28/03/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/02/2023
GPNX
NOTIFICATION PROCESSED BY IB
24/01/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
18/01/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
18/01/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/01/2023
PUBO
PUBLISHED FOR OPPOSITION
10/01/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/01/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/01/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/12/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/12/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/11/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/11/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
23/11/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/08/2022
GNFR
FINAL REFUSAL E-MAILED
11/08/2022
CNFR
FINAL REFUSAL WRITTEN
11/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/07/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/07/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/07/2022
RFNT
REFUSAL PROCESSED BY IB
10/05/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/04/2022
RFRR
REFUSAL PROCESSED BY MPU
18/04/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/04/2022
CNRT
NON-FINAL ACTION WRITTEN
12/04/2022
DOCK
ASSIGNED TO EXAMINER
30/03/2022
MAFR
APPLICATION FILING RECEIPT MAILED
21/08/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/08/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/08/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ORIGINALMINE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.